Please try another search
By Jennifer Rigby LONDON (Reuters) -Global health advocates have written to the makers of a key mpox diagnostic test to call for its price to be cut from around $20 per test to $5, to help tackle low...
Danaher Corporation (NYSE:DHR), a leading player in the Life Science Tools & Diagnostics sector, has recently garnered increased attention from analysts and investors alike. The company's diverse...
On Monday, Wolfe Research adjusted its stance on shares of Danaher Corporation (NYSE:DHR), upgrading the stock from Peerperform to Outperform and setting a new price target of $285.00. The research...
On Thursday, Wolfe Research made a significant adjustment to its rating for Danaher Corporation (NYSE:DHR), upgrading the stock from Peer Perform to Outperform. Accompanying this upgrade, the firm...
(Reuters) - Veralto raised its annual adjusted profit forecast on Wednesday, for the third time this year, as the water treatment solutions provider expects sustained demand for its chemical...
On Wednesday, TD Cowen maintained a positive stance on shares of Danaher Corporation (NYSE:DHR), with the firm's analyst updating the company's price target to $315 from the previous $310, while...
On Wednesday, KeyBanc Capital Markets adjusted its outlook on shares of Danaher Corporation (NYSE:DHR), increasing the price target from $290.00 to $310.00. The firm maintained its Overweight rating...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review